apixaban
Apixaban
Anticoagulation Therapy Management: Policy 900.3207
Clinical Guidelines:
Initiation/Dosing: Anticoagulation selection for patients with non-valvular atrial fibrillation. See Guideline 900.5008
Initiation/Other: Direct Oral Anticoagulant Use for Venous Thromboembolism, see Protocol 900.5206
Transitioning: Warfarin transition (to or from apixaban): See Guideline 900.5863
Surgery: Timing of Neuraxial Anesthesia and Anticoagulation: See Guideline 900.5681
Surgery: Periprocedural Management of Anticoagulation therapy: See Protocol 900.5011
Reversal: Reversal in bleeding patients or for emergent surgery: See Reversal Guideline 900.5010
Antithrombotic and Anticoagulant Treatment in Stroke: See 900.5018
Free 30-Day trial or $10 co-pay Coupons available electronically for Legacy Health
Apixaban
Anticoagulation Therapy Management: Policy 900.3207
Clinical Guidelines:
Initiation/Dosing: Anticoagulation selection for patients with non-valvular atrial fibrillation. See Guideline 900.5008
Initiation/Other: Direct Oral Anticoagulant Use for Venous Thromboembolism, see Protocol 900.5206
Transitioning: Warfarin transition (to or from apixaban): See Guideline 900.5863
Surgery: Timing of Neuraxial Anesthesia and Anticoagulation: See Guideline 900.5681
Surgery: Periprocedural Management of Anticoagulation therapy: See Protocol 900.5011
Reversal: Reversal in bleeding patients or for emergent surgery: See Reversal Guideline 900.5010
Antithrombotic and Anticoagulant Treatment in Stroke: See 900.5018
Free 30-Day trial or $10 co-pay Coupons available electronically for Legacy Health